Arsenal Investment Partners

Arsenal Capital Partners is a New York-based private equity investment firm focused on building middle-market companies in healthcare and industrial growth markets. The firm is not itself a drug developer, biotech, pharma, CRO, or CDMO, but it actively invests in and builds businesses across healthcare services, healthcare technology, life sciences tools, clinical trial optimization, and related outsourced services. Arsenal emphasizes company building, operational improvement, strategic acquisitions, and growth-oriented investing rather than developing an internal therapeutic pipeline. Its healthcare portfolio has included businesses such as WCG, CellCarta, Lumanity, and other companies serving pharma, biotech, providers, and patients. For biotech analyst purposes, Arsenal is best understood as a healthcare-focused private equity sponsor rather than an operating life sciences company.